Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00994942 · ClinicalTrials.gov registry record · NA
Bioequivalency Study of Morphine Sulfate Injection, Solution and Tablet Under Fasted Conditions
A NA study of Pain, sponsored by Roxane Laboratories.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT00994942: Completed NA study of Pain, sponsored by Roxane Laboratories.
NCT00994942 is a NA study of Pain that has completed, run by Roxane Laboratories. The registered enrollment target is 18 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00994942, a NA study of Pain, has completed, sponsored by Roxane Laboratories.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
Determine the pharmacokinetics and optimize study design for subsequent studies with morphine sulfate tablets and solution.
Conditions Studied
Interventions
- DRUG morphine sulfate
Study Locations (1)
Texas
- CEDRA Clinical Research - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2006-04 |
| Est. Completion | 2006-04 |
| Phase | NA |
What the finished NCT00994942 record still lists
NCT00994942 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 1 intervention - of which morphine sulfate is the first listed.
NCT00994942 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00994942 about?
NCT00994942 is a clinical study titled "Bioequivalency Study of Morphine Sulfate Injection, Solution and Tablet Under Fasted Conditions". Determine the pharmacokinetics and optimize study design for subsequent studies with morphine sulfate tablets and solution.
What is the current status of trial NCT00994942?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2006-04. Estimated completion is 2006-04.
What conditions does trial NCT00994942 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT00994942?
The interventions under investigation include: morphine sulfate (DRUG).
Who is sponsoring clinical trial NCT00994942?
This trial is sponsored by Roxane Laboratories, which has 93 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00994942 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00994942's enrollment target sits among peer trials
18 350th of 374 higher than 25 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Pain With Dementia
RECRUITING · NA
-
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia